Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Miko

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Neoplasma|July 5, 2002
Cytotoxicity and mode of action of the potential cytostatic drug oracinM Miko, M Poturnajova, R Soucek
Sangyo Igaku. Japanese Journal of Industrial Health|September 1, 1988
[Heart rate responses of fire-men to actual fire-fighting and their endurance capacity]S Oda, M Miko, S Taguchi
Drug Metabolism and Drug Interactions|January 1, 1991
Pseudomonas aeruginosa toxins: effect on Ehrlich carcinoma and Vero cells in vitroV Majtan, M Miko, A Hostacka
Cancer Research|October 1, 1979
Inhibition of energy metabolism in Ehrlich ascites cells treated with dactylarin in vitroM Miko, L Drobnica, B Chance
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Primary screening of cytotoxic activity of 6-purinyl-N-(2-chlordethyl) thiocarbamateM Miko, J Krepelka, M Melka
Reumatizam|January 1, 1978
[Lipid changes in gout in comparison with degenerative rheumatism]M Miko, M Degmecić, I Jajić
Folia Microbiologica|January 1, 1982
The effect of rifampicin on Mycobacterium smegmatisV Majtán, L' Drobnica, M Miko
Biochemical Pharmacology|December 11, 1991
Effects of benfluron and its two metabolites on respiratory processes in P388 murine leukemia and Ehrlich ascites cellsM Miko, J Krepelka, M Melka
Drug Metabolism and Drug Interactions|January 1, 1991
Primary screening and inhibition of macromolecular biosynthesis in Ehrlich ascites cells by benzo(C)fluorene derivativesM Miko, J Krepelka, M Melka
Reumatizam|January 1, 1977
[Liver diseases and the rheumatoid factor]S Petö, M Degmecić, M Miko
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Neoplasma|July 5, 2002
Cytotoxicity and mode of action of the potential cytostatic drug oracinM Miko, M Poturnajova, R Soucek
Sangyo Igaku. Japanese Journal of Industrial Health|September 1, 1988
[Heart rate responses of fire-men to actual fire-fighting and their endurance capacity]S Oda, M Miko, S Taguchi
Drug Metabolism and Drug Interactions|January 1, 1991
Pseudomonas aeruginosa toxins: effect on Ehrlich carcinoma and Vero cells in vitroV Majtan, M Miko, A Hostacka
Cancer Research|October 1, 1979
Inhibition of energy metabolism in Ehrlich ascites cells treated with dactylarin in vitroM Miko, L Drobnica, B Chance
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Primary screening of cytotoxic activity of 6-purinyl-N-(2-chlordethyl) thiocarbamateM Miko, J Krepelka, M Melka
Reumatizam|January 1, 1978
[Lipid changes in gout in comparison with degenerative rheumatism]M Miko, M Degmecić, I Jajić
Folia Microbiologica|January 1, 1982
The effect of rifampicin on Mycobacterium smegmatisV Majtán, L' Drobnica, M Miko
Biochemical Pharmacology|December 11, 1991
Effects of benfluron and its two metabolites on respiratory processes in P388 murine leukemia and Ehrlich ascites cellsM Miko, J Krepelka, M Melka
Drug Metabolism and Drug Interactions|January 1, 1991
Primary screening and inhibition of macromolecular biosynthesis in Ehrlich ascites cells by benzo(C)fluorene derivativesM Miko, J Krepelka, M Melka
Reumatizam|January 1, 1977
[Liver diseases and the rheumatoid factor]S Petö, M Degmecić, M Miko
Pageof 6